<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Analysis of most hematologic <z:hpo ids='HP_0002664'>neoplasms</z:hpo> indicates the involvement of one or more cell lineages in the bone marrow and/or the blood but rules out the involvement of <z:hpo ids='HP_0000001'>all</z:hpo> lineages in any one <z:hpo ids='HP_0002664'>neoplasm</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>It is important to detect lineage involvement in order to clarify which stem cells are involved in <z:hpo ids='HP_0001909'>leukemia</z:hpo>, to predict prognosis, and to select appropriate treatment </plain></SENT>
<SENT sid="2" pm="."><plain>Our aim was to study the cell lineage involvement of some of the recurrent chromosomal abnormalities seen in <z:hpo ids='HP_0004377'>hematological neoplasms</z:hpo> </plain></SENT>
<SENT sid="3" pm="."><plain>The direct <z:mp ids='MP_0000002'>morphology</z:mp>-antibody-chromosomes (MAC) method was used </plain></SENT>
<SENT sid="4" pm="."><plain>The deletion 20q in <z:mpath ids='MPATH_512'>myeloproliferative diseases</z:mpath> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>), the deletion of 5q and t(1;7) in <z:hpo ids='HP_0002863'>myelodysplastic syndromes</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MDS</z:e>), and t(3;3) in <z:hpo ids='HP_0004808'>acute myeloid leukemia</z:hpo> subtype M7 (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M7) were seen in <z:hpo ids='HP_0000001'>all</z:hpo> or at least in two myeloid lineages </plain></SENT>
<SENT sid="5" pm="."><plain>These were interpreted as stem cell abnormalities </plain></SENT>
<SENT sid="6" pm="."><plain>Deletion 13q in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">MPD</z:e>, t(8;21) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M2 and t(15;17) in <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">AML</z:e>-M3 were seen in granulocytic lineages only; t(14;18) in non-Hodgkin's <z:hpo ids='HP_0002665'>lymphoma</z:hpo> and <z:mp ids='MP_0004027'>trisomy</z:mp> 12 as the sole abnormality in <z:hpo ids='HP_0005550'>chronic lymphocytic leukemia</z:hpo> (B-CLL) were seen only in immunoglobulin light chain clonal B cells; inversion 14 in T-CLL was seen only in T cells, whereas t(15;14) in <z:hpo ids='HP_0011009'>acute</z:hpo> lymphocytic <z:hpo ids='HP_0001909'>leukemia</z:hpo> with <z:hpo ids='HP_0001880'>eosinophilia</z:hpo> (ALL-EO) was seen in lymphoid stem cells but not in mature granulocytes or lymphocytes </plain></SENT>
<SENT sid="7" pm="."><plain>Additional abnormalities (in addition to the Philadelphia chromosome) in <z:hpo ids='HP_0011010'>chronic</z:hpo> myeloid <z:hpo ids='HP_0001909'>leukemia</z:hpo> (<z:mp ids='MP_0005481'>CML</z:mp>) were seen in <z:hpo ids='HP_0000001'>all</z:hpo> myeloid cell lineages and also in mature granulocytes, B cells, and large granular lymphocytes </plain></SENT>
<SENT sid="8" pm="."><plain>Abnormalities in <z:e sem="disease" ids="C0019829" disease_type="Neoplastic Process" abbrv="hd">Hodgkin's disease</z:e> were restricted to CD30-positive Reed-Sternberg cells </plain></SENT>
<SENT sid="9" pm="."><plain><z:mp ids='MP_0004027'>Trisomy</z:mp> 8 and <z:mp ids='MP_0004026'>monosomy</z:mp> 7 are abnormalities that may be present in either stem cells or any of the single cell lineages </plain></SENT>
</text></document>